Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Current Pain and Headache Reports
Erschienen in: Current Pain and Headache Reports 4/2024

16.02.2024 | Chronic Daily Headache (S-J Wang and S-P Chen, Section Editors)

Influences of Genetic and Environmental Factors on Chronic Migraine: A Narrative Review

verfasst von: Po-Kuan Yeh, Yu-Chin An, Kuo-Sheng Hung, Fu-Chi Yang

Erschienen in: Current Pain and Headache Reports | Ausgabe 4/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

In this narrative review, we aim to summarize recent insights into the complex interplay between environmental and genetic factors affecting the etiology, development, and progression of chronic migraine (CM).

Recent Findings

Environmental factors such as stress, sleep dysfunction, fasting, hormonal changes, weather patterns, dietary compounds, and sensory stimuli are critical triggers that can contribute to the evolution of episodic migraine into CM. These triggers are particularly influential in genetically predisposed individuals. Concurrently, genome-wide association studies (GWAS) have revealed over 100 genetic loci linked to migraine, emphasizing a significant genetic basis for migraine susceptibility.

Summary

In CM, environmental and genetic factors are of equal importance and contribute to the pathophysiology of the condition. Understanding the bidirectional interactions between these elements is crucial for advancing therapeutic approaches and preventive strategies. This balanced perspective encourages continued research into the complex gene-environment nexus to improve our understanding and management of CM.
Literatur
1.
Eigenbrodt AK, Ashina H, Khan S, Diener HC, Mitsikostas DD, Sinclair AJ, Pozo-Rosich P, Martelletti P, Ducros A, Lantéri-Minet M, Braschinsky M, Del Rio MS, Daniel O, Özge A, Mammadbayli A, Arons M, Skorobogatykh K, Romanenko V, Terwindt GM, Paemeleire K, Sacco S, Reuter U, Lampl C, Schytz HW, Katsarava Z, Steiner TJ, Ashina M. Diagnosis and management of migraine in ten steps. Nat Rev Neurol. 2021;17:501–14.PubMedPubMedCentralCrossRef
2.
Grangeon L, Lange KS, Waliszewska-Prosół M, Onan D, Marschollek K, Wiels W, Mikulenka P, Farham F, Gollion C, Ducros A, European Headache Federation School of Advanced Studies (EHF-SAS). Genetics of migraine: where are we now? J Headache Pain. 2023;24:12.
3.
•• Hautakangas H, Winsvold BS, Ruotsalainen SE, Bjornsdottir G, Harder AVE, Kogelman LJA, Thomas LF, Noordam R, Benner C, Gormley P, Artto V, Banasik K, Bjornsdottir A, Boomsma DI, Brumpton BM, Burgdorf KS, Buring JE, Chalmer MA, de Boer I, Dichgans M, Erikstrup C, Färkkilä M, Garbrielsen ME, Ghanbari M, Hagen K, Häppölä P, Hottenga JJ, Hrafnsdottir MG, Hveem K, Johnsen MB, Kähönen M, Kristoffersen ES, Kurth T, Lehtimäki T, Lighart L, Magnusson SH, Malik R, Pedersen OB, Pelzer N, Penninx BWJH, Ran C, Ridker PM, Rosendaal FR, Sigurdardottir GR, Skogholt AH, Sveinsson OA, Thorgeirsson TE, Ullum H, Vijfhuizen LS, Widén E, van Dijk KW, International Headache Genetics Consortium, HUNT All-in Headache, Danish Blood Donor Study Genomic Cohort, Aromaa A, Belin AC, Freilinger T, Ikram MA, Järvelin MR, Raitakari OT, Terwindt GM, Kallela M, Wessman M, Olesen J, Chasman DI, Nyholt DR, Stefánsson H, Stefansson K, van den Maagdenberg AMJM, Hansen TF, Ripatti S, Zwart JA, Palotie A, Pirinen M. Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles. Nat Genet. 2022;54:152–60. The research identified 123 risk loci using a genome-wide association study, including 86 previously unidentified loci. It offers valuable insights into the genetic components specific to different subtypes and further supports the significance of neurovascular mechanisms in the pathophysiology of migraines.
4.
Martinelli D, Pocora MM, De Icco R, Putortì A, Tassorelli C. Triggers of migraine: where do we stand? Curr Opin Neurol. 2022;35:360–6.PubMedCrossRef
5.
Stubberud A, Buse DC, Kristoffersen ES, Linde M, Tronvik E. Is there a causal relationship between stress and migraine? Current evidence and implications for management. J Headache Pain. 2021;22:155.PubMedPubMedCentralCrossRef
6.
Radat F. What is the link between migraine and psychiatric disorders? From epidemiology to therapeutics. Rev Neurol (Paris). 2021;177:821–6.PubMedCrossRef
7.
Pistoia F, Salfi F, Saporito G, Ornello R, Frattale I, D’Aurizio G, Tempesta D, Ferrara M, Sacco S. Behavioral and psychological factors in individuals with migraine without psychiatric comorbidities. J Headache Pain. 2022;23:110.PubMedPubMedCentralCrossRef
8.
Stankewitz A, May A. Increased limbic and brainstem activity during migraine attacks following olfactory stimulation. Neurology. 2011;77:476–82.PubMedCrossRef
9.
• Hadjikhani N, Ward N, Boshyan J, Napadow V, Maeda Y, Truini A, Caramia F, Tinelli E, Mainero C. The missing link: enhanced functional connectivity between amygdala and visceroceptive cortex in migraine. Cephalalgia. 2013;33:1264–8. This study proposes that increased connectivity between the amygdala and visceroceptive cortex in individuals with chronic migraine may exacerbate migraine symptoms and increase the likelihood of developing chronic migraines. This finding holds potential implications for disease prognosis and genetic factor identification.PubMedPubMedCentralCrossRef
10.
Torres-Ferrus M, Pareto D, Gallardo VJ, Cuberas-Borrós G, Alpuente A, Caronna E, Vila-Balló A, Lorenzo-Bosquet C, Castell-Conesa J, Rovira A, Pozo-Rosich P. Cortical metabolic and structural differences in patients with chronic migraine. An exploratory (18)FDG-PET and MRI study. J Headache Pain. 2021;22:75.
11.
Bae JY, Sung HK, Kwon NY, Go HY, Kim TJ, Shin SM, Lee S. Cognitive behavioral therapy for migraine headache: a systematic review and meta-analysis. Medicina (Kaunas). 2021;58.
12.
Sacmaci H, Tanik N, Inan LE. Current perspectives on the impact of chronic migraine on sleep quality: a literature review. Nat Sci Sleep. 2022;14:1783–800.PubMedPubMedCentralCrossRef
13.
Vgontzas A, Pavlovic JM. Sleep disorders and migraine: review of literature and potential pathophysiology mechanisms. Headache. 2018;58:1030–9.PubMedPubMedCentralCrossRef
14.
•• Kuburas A, Russo AF. Shared and independent roles of CGRP and PACAP in migraine pathophysiology. J Headache Pain. 2023;24:34. This study investigated the functions of neuropeptides CGRP and PACAP in the pathophysiology of migraines. It highlights the effect of PACAP-38 and PACAP-27 on migraines, providing insights into potential treatment approaches. These findings could pave the way for the development of innovative therapies targeting CGRP and PACAP.PubMedPubMedCentralCrossRef
15.
Messina A, Bitetti I, Precenzano F, Iacono D, Messina G, Roccella M, Parisi L, Salerno M, Valenzano A, Maltese A, Salerno M, Sessa F, Albano GD, Marotta R, Villano I, Marsala G, Zammit C, Lavano F, Monda M, Cibelli G, Lavano SM, Gallai B, Toraldo R, Monda V, Carotenuto M. Non-rapid eye movement sleep parasomnias and migraine: a role of orexinergic projections. Front Neurol. 2018;9:95.PubMedPubMedCentralCrossRef
16.
Korabelnikova EA, Danilov AB, Danilov AB, Vorobyeva YD, Latysheva NV, Artemenko AR. Sleep disorders and headache: a review of correlation and mutual influence. Pain Ther. 2020;9:411–25.PubMedPubMedCentralCrossRef
17.
Tiseo C, Vacca A, Felbush A, Filimonova T, Gai A, Glazyrina T, Hubalek IA, Marchenko Y, Overeem LH, Piroso S, Tkachev A, Martelletti P, Sacco S, European Headache Federation School of Advanced Studies (EHF-SAS). Migraine and sleep disorders: a systematic review. J Headache Pain. 2020;21:126.
18.
Tu AY, Crawford MR, Dawson SC, Fogg LF, Turner AD, Wyatt JK, Crisostomo MI, Chhangani BS, Kushida CA, Edinger JD, Abbott SM, Malkani RG, Attarian HP, Zee PC, Ong JC. A randomized controlled trial of cognitive behavioral therapy for insomnia and PAP for obstructive sleep apnea and comorbid insomnia: effects on nocturnal sleep and daytime performance. J Clin Sleep Med. 2022;18:789–800.PubMedPubMedCentralCrossRef
19.
Yadav RK, Kalita J, Misra UK. A study of triggers of migraine in India. Pain Med. 2010;11:44–7.PubMedCrossRef
20.
21.
Friedman BW, Lipton RB. Headache emergencies: diagnosis and management. Neurol Clin. 2012;30(43–59):vii.PubMed
22.
Kelman L. The triggers or precipitants of the acute migraine attack. Cephalalgia. 2007;27:394–402.PubMedCrossRef
23.
Kimoto K, Aiba S, Takashima R, Suzuki K, Takekawa H, Watanabe Y, Tatsumoto M, Hirata K. Influence of barometric pressure in patients with migraine headache. Intern Med. 2011;50:1923–8.PubMedCrossRef
24.
Akgün N, Acıman Demirel E, Açıkgöz M, Çelebi U, Köktürk F, Atasoy HT. The effect of weather variables on the severity, duration, and frequency of headache attacks in the cases of episodic migraine and episodic tension-type headache. Turk J Med Sci. 2021;51:1406–12.PubMedPubMedCentralCrossRef
25.
Zebenholzer K, Rudel E, Frantal S, Brannath W, Schmidt K, Wöber-Bingöl C, Wöber C. Migraine and weather: a prospective diary-based analysis. Cephalalgia. 2011;31:391–400.PubMedCrossRef
26.
Ordás CM, Cuadrado ML, Rodríguez-Cambrón AB, Casas-Limón J, del Prado N, Porta-Etessam J. Increase in body temperature during migraine attacks. Pain Med. 2013;14:1260–4.PubMedCrossRef
27.
Cooke LJ, Rose MS, Becker WJ. Chinook winds and migraine headache. Neurology. 2000;54:302–7.PubMedCrossRef
28.
29.
Paterni I, Granchi C, Katzenellenbogen JA, Minutolo F. Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligands and clinical potential. Steroids. 2014;90:13–29.PubMedCrossRef
30.
Costa C, Tozzi A, Rainero I, Cupini LM, Calabresi P, Ayata C, Sarchielli P. Cortical spreading depression as a target for anti-migraine agents. J Headache Pain. 2013;14:62.PubMedPubMedCentralCrossRef
31.
Neri I, Granella F, Nappi R, Manzoni GC, Facchinetti F, Genazzani AR. Characteristics of headache at menopause: a clinico-epidemiologic study. Maturitas. 1993;17:31–7.PubMedCrossRef
32.
Vetvik KG, MacGregor EA. Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol. 2017;16:76–87.PubMedCrossRef
33.
Hranilovich JA, Kaiser EA, Pace A, Barber M, Ziplow J. Headache in transgender and gender-diverse patients: a narrative review. Headache. 2021;61:1040–50.PubMedCrossRef
34.
35.
Calhoun A, Ford S, Pruitt A. The impact of extended-cycle vaginal ring contraception on migraine aura: a retrospective case series. Headache. 2012;52:1246–53.PubMedCrossRef
36.
Chauvel V, Vamos E, Pardutz A, Vecsei L, Schoenen J, Multon S. Effect of systemic kynurenine on cortical spreading depression and its modulation by sex hormones in rat. Exp Neurol. 2012;236:207–14.PubMedCrossRef
37.
Akerman S, Goadsby PJ. Dopamine and migraine: biology and clinical implications. Cephalalgia. 2007;27:1308–14.PubMedCrossRef
38.
D’Andrea G, D’Amico D, Bussone G, Bolner A, Aguggia M, Saracco MG, Galloni E, De Riva V, Colavito D, Leon A, Rosteghin V, Perini F. The role of tyrosine metabolism in the pathogenesis of chronic migraine. Cephalalgia. 2013;33:932–7.PubMedCrossRef
39.
Gonzalez A, Hyde E, Sangwan N, Gilbert JA, Viirre E, Knight R. Migraines are correlated with higher levels of nitrate-, nitrite-, and nitric oxide-reducing oral microbes in the American Gut Project Cohort. mSystems. 2016;1.
40.
Fried NT, Elliott MB, Oshinsky ML. The role of adenosine signaling in headache: a review. Brain Sci. 2017;7.
41.
Strandwitz P, Kim KH, Terekhova D, Liu JK, Sharma A, Levering J, McDonald D, Dietrich D, Ramadhar TR, Lekbua A, Mroue N, Liston C, Stewart EJ, Dubin MJ, Zengler K, Knight R, Gilbert JA, Clardy J, Lewis K. GABA-modulating bacteria of the human gut microbiota. Nat Microbiol. 2019;4:396–403.PubMedCrossRef
42.
Hindiyeh NA, Zhang N, Farrar M, Banerjee P, Lombard L, Aurora SK. The role of diet and nutrition in migraine triggers and treatment: a systematic literature review. Headache. 2020;60:1300–16.PubMedPubMedCentralCrossRef
43.
Nowaczewska M, Wiciński M, Kaźmierczak W, Kaźmierczak H. To eat or not to eat: a review of the relationship between chocolate and migraines. Nutrients. 2020;12.
44.
•• Liu H, Wang D, Wu F, Dong Z, Yu S. Association between inflammatory potential of diet and self-reported severe headache or migraine: a cross-sectional study of the National Health and Nutrition Examination Survey. Nutrition. 2023;113: 112098. The research involving 10,359 individuals demonstrated a correlation between elevated dietary inflammatory index (DII) scores and the occurrence of migraines. This finding highlights the potential of dietary adjustments as a non-pharmacological strategy for managing migraines.PubMedCrossRef
45.
46.
Rocha-Filho PA, Marques KS, Torres RC, Leal KN. Migraine, osmophobia, and anxiety. Pain Med. 2016;17:776–80.PubMed
47.
Mese Pekdemir E, Tanik N. Clinical significance of osmophobia and its effect on quality of life in people with migraine. Acta Neurol Belg. 2023;123:1747–55.PubMedCrossRef
48.
49.
Ishikawa T, Tatsumoto M, Maki K, Mitsui M, Hasegawa H, Hirata K. Identification of everyday sounds perceived as noise by migraine patients. Intern Med. 2019;58:1565–72.PubMedPubMedCentralCrossRef
50.
Hauge AW, Asghar MS, Schytz HW, Christensen K, Olesen J. Effects of tonabersat on migraine with aura: a randomised, double-blind, placebo-controlled crossover study. Lancet Neurol. 2009;8:718–23.PubMedCrossRef
51.
• Harder AVE, Terwindt GM, Nyholt DR, van den Maagdenberg AMJM. Migraine genetics: status and road forward. Cephalalgia. 2023;43:3331024221145962. This article offers a thorough overview of recent genetic findings related to migraine.PubMedCrossRef
52.
• Louter MA, Fernandez-Morales J, de Vries B, Winsvold B, Anttila V, Fernandez-Cadenas I, Vila-Pueyo M, Sintas C, van Duijn CM, Cormand B, Álvarez-Sabin J, Montaner J, Ferrari MD, van den Maagdenberg A, Palotie A, Zwart JA, Macaya A, Terwindt GM, Pozo-Rosich P. Candidate-gene association study searching for genetic factors involved in migraine chronification. Cephalalgia. 2015;35:500–7. The article represents an initial thorough genetic association analysis for the process of migraine chronification. The results suggest a lack of significant findings, indicating the need for future studies to utilize larger datasets or alternative genetic methodologies in order to elucidate the genetic basis of chronic migraine.PubMedCrossRef
53.
Chalmer MA, Rasmussen AH, International Headache Genetics Consortium, 23andme Research Team, Kogelman LJA, Olesen J, Hansen TF. Chronic migraine: genetics or environment? Eur J Neurol. 2021;28:1726–36.
54.
Shibata M, Tang C. Implications of transient receptor potential cation channels in migraine pathophysiology. Neurosci Bull. 2021;37:103–16.PubMedCrossRef
55.
Yakubova A, Davidyuk Y, Tohka J, Khayrutdinova O, Kudryavtsev I, Nurkhametova D, Kamshilin A, Giniatullin R, Rizvanov A. Searching for predictors of migraine chronification: a pilot study of 1911A>G polymorphism of TRPV1 gene in episodic versus chronic migraine. J Mol Neurosci. 2021;71:618–24.PubMedCrossRef
56.
Ling YH, Chen SP, Fann CS, Wang SJ, Wang YF. TRPM8 genetic variant is associated with chronic migraine and allodynia. J Headache Pain. 2019;20:115.PubMedPubMedCentralCrossRef
57.
Okamoto N, Okumura M, Tadokoro O, Sogawa N, Tomida M, Kondo E. Effect of single-nucleotide polymorphisms in TRPV1 on burning pain and capsaicin sensitivity in Japanese adults. Mol Pain. 2018;14:1744806918804439.PubMedPubMedCentralCrossRef
58.
Bernardini N, Neuhuber W, Reeh PW, Sauer SK. Morphological evidence for functional capsaicin receptor expression and calcitonin gene-related peptide exocytosis in isolated peripheral nerve axons of the mouse. Neuroscience. 2004;126:585–90.PubMedCrossRef
59.
Cortés-Montero E, Rodríguez-Muñoz M, Ruiz-Cantero MDC, Cobos EJ, Sánchez-Blázquez P, Garzón-Niño J. Calmodulin supports TRPA1 channel association with opioid receptors and glutamate NMDA receptors in the nervous tissue. Int J Mol Sci. 2020;22.
60.
Wang M, Gu Y, Meng S, Kang L, Yang J, Sun D, Liu Y, Wan Z, Shan Y, Xue D, Su C, Li S, Yan R, Liu Y, Zhao Y, Pan Y. Association between TRP channels and glutamatergic synapse gene polymorphisms and migraine and the comorbidities anxiety and depression in a Chinese population. Front Genet. 2023;14:1158028.PubMedPubMedCentralCrossRef
61.
62.
Wang K, Gaitsch H, Poon H, Cox NJ, Rzhetsky A. Classification of common human diseases derived from shared genetic and environmental determinants. Nat Genet. 2017;49:1319–25.PubMedPubMedCentralCrossRef
63.
Huang C, Chen SP, Huang YH, Chen HY, Wang YF, Lee MH, Wang SJ. HLA class I alleles are associated with clinic-based migraine and increased risks of chronic migraine and medication overuse. Cephalalgia. 2020;40:493–502.PubMedCrossRef
64.
Peroutka SJ. Migraine: a chronic sympathetic nervous system disorder. Headache. 2004;44:53–64.PubMedCrossRef
65.
Ghosh J, Pradhan S, Mittal B. Identification of a novel ANKK1 and other dopaminergic (DRD2 and DBH) gene variants in migraine susceptibility. Neuromolecular Med. 2013;15:61–73.PubMedCrossRef
66.
Todt U, Netzer C, Toliat M, Heinze A, Goebel I, Nürnberg P, Göbel H, Freudenberg J, Kubisch C. New genetic evidence for involvement of the dopamine system in migraine with aura. Hum Genet. 2009;125:265–79.PubMedCrossRef
67.
Sezer S, Kurt S, Ates O. Analysis of dopamine beta hydroxylase gene polymorphisms in migraine. Clin Neurol Neurosurg. 2016;145:96–100.PubMedCrossRef
68.
Barbanti P, Guadagni F, De Marchis ML, Ialongo C, Egeo G, Fofi L, Aurilia C, Lovero D, Della-Morte D, Ferroni P, Palmirotta R. Dopamine-beta-hydroxylase 19-bp insertion/deletion polymorphism affects medication overuse in patients with chronic migraine. Neurol Sci. 2019;40:1717–24.PubMedCrossRef
69.
Emin Erdal M, Herken H, Yilmaz M, Bayazit YA. Significance of the catechol-O-methyltransferase gene polymorphism in migraine. Brain Res Mol Brain Res. 2001;94:193–6.PubMedCrossRef
70.
Takigawa H, Kowa H, Nakashima K. No associations between five polymorphisms in COMT gene and migraine. Acta Neurol Scand. 2017;135:225–30.PubMedCrossRef
71.
Russell FA, King R, Smillie SJ, Kodji X, Brain SD. Calcitonin gene-related peptide: physiology and pathophysiology. Physiol Rev. 2014;94:1099–142.PubMedPubMedCentralCrossRef
72.
Russo AF. Calcitonin gene-related peptide (CGRP): a new target for migraine. Annu Rev Pharmacol Toxicol. 2015;55:533–52.PubMedCrossRef
73.
Wang YF, Wang SJ. CGRP Targeting therapy for chronic migraine-evidence from clinical trials and real-world studies. Curr Pain Headache Rep. 2022;26:543–54.PubMedCrossRef
74.
Wattiez AS, Sowers LP, Russo AF. Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting. Expert Opin Ther Targets. 2020;24:91–100.PubMedPubMedCentralCrossRef
75.
Rubino E, Boschi S, Giorgio E, Pozzi E, Marcinnò A, Gallo E, Roveta F, Grassini A, Brusco A, Rainero I. Analysis of the DNA methylation pattern of the promoter region of calcitonin gene-related peptide 1 gene in patients with episodic migraine: an exploratory case-control study. Neurobiol Pain. 2022;11: 100089.PubMedPubMedCentralCrossRef
76.
Fila M, Sobczuk A, Pawlowska E, Blasiak J. Epigenetic connection of the calcitonin gene-related peptide and its potential in migraine. Int J Mol Sci. 2022;23.
77.
Osko JD, Christianson DW. Methods for the expression, purification, and crystallization of histone deacetylase 6-inhibitor complexes. Methods Enzymol. 2019;626:447–74.PubMedPubMedCentralCrossRef
78.
Dai Y, Wei T, Shen Z, Bei Y, Lin H, Dai H. Classical HDACs in the regulation of neuroinflammation. Neurochem Int. 2021;150:105182.PubMedCrossRef
79.
80.
Urru M, Buonvicino D, Pistolesi A, Paccosi S, Chiarugi A. Histone deacetylase inhibitors counteract CGRP signaling and pronociceptive sensitization in a rat model of medication overuse headache. J Pain. 2022;23:1874–84.PubMedCrossRef
81.
Bertels Z, Singh H, Dripps I, Siegersma K, Tipton AF, Witkowski WD, Sheets Z, Shah P, Conway C, Mangutov E, Ao M, Petukhova V, Karumudi B, Petukhov PA, Baca SM, Rasenick MM, Pradhan AA. Neuronal complexity is attenuated in preclinical models of migraine and restored by HDAC6 inhibition. Elife. 2021;10.
82.
An YC, Tsai CL, Liang CS, Lin YK, Lin GY, Tsai CK, Liu Y, Chen SJ, Tsai SH, Hung KS, Yang FC. Identification of novel genetic variants associated with insomnia and migraine comorbidity. Nat Sci Sleep. 2022;14:1075–87.PubMedPubMedCentralCrossRef
83.
Gentile G, Missori S, Borro M, Sebastianelli A, Simmaco M, Martelletti P. Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine. J Headache Pain. 2010;11:151–6.PubMedPubMedCentralCrossRef
84.
Gentile G, Borro M, Lala N, Missori S, Simmaco M, Martelletti P. Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine. J Headache Pain. 2010;11:431–5.PubMedPubMedCentralCrossRef
85.
Moreno-Mayordomo R, Ruiz M, Pascual J, Gallego de la Sacristana M, Vidriales I, Sobrado M, Cernuda-Morollon E, Gago-Veiga AB, Garcia-Azorin D, Telleria JJ, Guerrero AL. CALCA and TRPV1 genes polymorphisms are related to a good outcome in female chronic migraine patients treated with onabotulinumtoxinA. J Headache Pain. 2019;20:39.
86.
Buse DC, Greisman JD, Baigi K, Lipton RB. Migraine progression: a systematic review. Headache. 2019;59:306–38.PubMedCrossRef
87.
88.
Mormile R, Mazzei G, Vittori G, De Michele M, Squarcia U. Insomnia and shift-work sleep disorder: a crosstalk between glutamate excitotoxicity and decreased GABAergic neurotransmission? Sleep Biol Rhythms. 2012;10:340–1.CrossRef
89.
Ligthart L, Hottenga JJ, Lewis CM, Farmer AE, Craig IW, Breen G, Willemsen G, Vink JM, Middeldorp CM, Byrne EM, Heath AC, Madden PA, Pergadia ML, Montgomery GW, Martin NG, Penninx BW, McGuffin P, Boomsma DI, Nyholt DR. Genetic risk score analysis indicates migraine with and without comorbid depression are genetically different disorders. Hum Genet. 2014;133:173–86.PubMedCrossRef
90.
Ashina S, Serrano D, Lipton RB, Maizels M, Manack AN, Turkel CC, Reed ML, Buse DC. Depression and risk of transformation of episodic to chronic migraine. J Headache Pain. 2012;13:615–24.PubMedPubMedCentralCrossRef
91.
Tsai MC, Tsai CL, Liang CS, Lin YK, Lin GY, Tsai CK, Yeh PK, Liu Y, Hung KS, Yang FC. Identification of genetic risk loci for depression and migraine comorbidity in Han Chinese residing in Taiwan. Front Psychiatry. 2022;13:1067503.PubMedCrossRef
92.
93.
Lee SH, Kang Y, Cho SJ. Subjective cognitive decline in patients with migraine and its relationship with depression, anxiety, and sleep quality. J Headache Pain. 2017;18:77.PubMedPubMedCentralCrossRef
94.
Yeh PK, Liang CS, Tsai CL, Lin YK, Lin GY, Tsai CK, Tsai MC, Liu Y, Tai YM, Hung KS, Yang FC. Genetic variants associated with subjective cognitive decline in patients with migraine. Front Aging Neurosci. 2022;14:860604.PubMedPubMedCentralCrossRef
95.
Niftullayev S, Lamarche-Vane N. Regulators of Rho GTPases in the nervous system: molecular implication in axon guidance and neurological disorders. Int J Mol Sci. 2019;20.
96.
Serafini G, Pompili M, Innamorati M, Gentile G, Borro M, Lamis DA, Lala N, Negro A, Simmaco M, Girardi P, Martelletti P. Gene variants with suicidal risk in a sample of subjects with chronic migraine and affective temperamental dysregulation. Eur Rev Med Pharmacol Sci. 2012;16:1389–98.PubMed
97.
Zobdeh F, Eremenko II, Akan MA, Tarasov VV, Chubarev VN, Schiöth HB, Mwinyi J. The epigenetics of migraine. Int J Mol Sci. 2023;24(11).
98.
• Winsvold BS, Palta P, Eising E, Page CM, International Headache Genetics Consortium, van den Maagdenberg AM, Palotie A, Zwart JA. Epigenetic DNA methylation changes associated with headache chronification: a retrospective case-control study. Cephalalgia. 2018;38:312–22. The study identified possible epigenetic elements in the transition from episodic to chronic headache, indicating the participation of brain-expressed genes, pathways associated with synaptic plasticity, and hormonal regulation.
99.
Camara MS, Martin Bujanda M, Mendioroz IM. Epigenetic changes in headache. Neurologia (Engl Ed). 2021;36:369–76.PubMed
100.
Metadaten
Titel
Influences of Genetic and Environmental Factors on Chronic Migraine: A Narrative Review
verfasst von
Po-Kuan Yeh
Yu-Chin An
Kuo-Sheng Hung
Fu-Chi Yang
Publikationsdatum
16.02.2024
Verlag
Springer US
Erschienen in
Current Pain and Headache Reports / Ausgabe 4/2024
Print ISSN: 1531-3433
Elektronische ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-024-01228-4

Weitere Artikel der Ausgabe 4/2024

Current Pain and Headache Reports 4/2024 Zur Ausgabe

Non-pharmacologic Aspects of Pain, Migraine, and Headache (D Buse, Section Editor)

A Role for Visual Art Therapy in the Management of Migraine

Anesthetic Techniques in Pain Management (D Wang, Section Editor)

Efficacy and Safety of Ketamine-Dexmedetomidine Versus Ketamine-Propofol Combination for Periprocedural Sedation: A Systematic Review and Meta-analysis

Concussion and Head Injury (A Kaye, Section Editor)

Treatment Options for Posttraumatic Headache: A Current Review of the Literature

Chronic Pain Medicine (O Viswanath, Section Editor)

The Diagnostic Value of Carnett’s Test with Chronic Abdominal Pain: A Narrative Review

Neuropathic Pain (A Abd-Elsayed, Section Editor)

Infrapatellar Branch of the Saphenous Nerve: Therapeutic Approaches to Chronic Knee Pain

Chronic Daily Headache (S-J Wang and S-P Chen, Section Editors)

Utility of Repetitive Transcranial Magnetic Stimulation for Chronic Daily Headache Prophylaxis: A Systematic Review and Meta-Analysis

Neu im Fachgebiet AINS

Mit dem Seitenschneider gegen das Reißverschluss-Malheur

03.06.2024 Urologische Notfallmedizin Nachrichten

Wer ihn je erlebt hat, wird ihn nicht vergessen: den Schmerz, den die beim Öffnen oder Schließen des Reißverschlusses am Hosenschlitz eingeklemmte Haut am Penis oder Skrotum verursacht. Eine neue Methode für rasche Abhilfe hat ein US-Team getestet.

Blutdrucksenkung schon im Rettungswagen bei akutem Schlaganfall?

31.05.2024 Apoplex Nachrichten

Der optimale Ansatz für die Blutdruckkontrolle bei Patientinnen und Patienten mit akutem Schlaganfall ist noch nicht gefunden. Ob sich eine frühzeitige Therapie der Hypertonie noch während des Transports in die Klinik lohnt, hat jetzt eine Studie aus China untersucht.

Ähnliche Überlebensraten nach Reanimation während des Transports bzw. vor Ort

29.05.2024 Reanimation im Kindesalter Nachrichten

Laut einer Studie aus den USA und Kanada scheint es bei der Reanimation von Kindern außerhalb einer Klinik keinen Unterschied für das Überleben zu machen, ob die Wiederbelebungsmaßnahmen während des Transports in die Klinik stattfinden oder vor Ort ausgeführt werden. Jedoch gibt es dabei einige Einschränkungen und eine wichtige Ausnahme.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren
Bildnachweise